Agios' Q1 Loss Narrower Than Expected, Revenues Lag Estimates

Agios Pharmaceuticals (AGIO) incurred a loss of $1.55 per share in the first quarter of 2025, narrower than the Zacks Consensus Estimate of a loss of$1.80. In the year-ago quarter, the company had reported a loss per share of $1.45.AGIO reported revenues of$8.7 million for the first quarter, which missed the Zacks Consensus Estimate of $10 million. Revenues increased 6.1$8.2 million. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.)Year to da ...